ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock
Work
Year: 2024
Type: article
Abstract: Background Angiotensin-converting enzyme inhibitor (ACEi) and angiotensin receptor blockers (ARB) medications are widely prescribed. We sought to assess how pre-admission use of these medications mig... more
Source: Critical Care
Authors Daniel E. Leisman, Damian Handisides, Laurence W. Busse, Mark C. Chappell, Lakhmir S. Chawla +9 more
Institutions Massachusetts General Hospital, La Jolla Pharmaceutical (United States), Innoviva (United States), Emory University, Wake Forest University +9 more
Cites: 25
Cited by: 14
Related to: 10
FWCI: 19.36
Citation percentile (by year/subfield): 100
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,931